AI-generated summary
The authors report a case study of one patient with biopsy-proven infraorbital linear morphea treated with 940 nm near-infrared light photobiomodulation three times weekly for 8 months. They describe excellent cosmetic results without textural changes or hypopigmentation, and suggest the approach may be potentially amenable to home use.
- Who or what was studied
- One patient with biopsy-proven infraorbital linear morphea and Fitzpatrick phototype III skin
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The report describes a single patient, so the findings cannot be generalized and no control group was used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Case report, Laser, Photodynamic therapy, Inflammation, Phototherapy, Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.